New filing reveals Cigna's plans for Express Scripts

Express Scripts will remain in St. Louis following the company's sale to Connecticut-based Cigna, according to a securities filing Wednesday. The $67 billion deal was announced in March and is expected to close before the end of the year. The Express Scripts unit, to be led by current CEO Tim Wentworth, will continue to operate independently, the filing said. Wentworth will be the president of the Express Scripts division, reporting into the combined company’s CEO. Four of Express Scripts' current…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news